Adverse Drug Effects
Frequency of new type 2 diabetes evaluated in patients taking antipsychotics
Published in Drug Week, November 15th, 2002
An analysis presented at the annual meeting of the Institute on Psychiatric Services of the American Psychiatric Association evaluated the frequencies of newly treated type 2 diabetes in patients treated with antipsychotic medications, including risperidone, olanzapine, Seroquel (quetiapine fumarate), and conventional antipsychotics, compared with patients who did not receive antipsychotic treatment.
A statement from AstraZeneca, maker of Seroquel, said a low percentage of patients in the study who were on Seroquel required treatment for type 2 diabetes.
Claims data within a health plan from nearly 17,000 patients with psychosis were analyzed using...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2002-11-15)
More Articles from Drug Week
- Alzheimer Disease
OHSU takes part in unique treatment trial - Dementia
Alzheimer drug effective against vascular dementias - Genital Herpes
Therapeutic vaccine's safety shown in clinical evaluation - Influenza
FluINsure vaccine results presented at ICAAC - Pulmonary Embolism
Abbott receives FDA approval to reintroduce Abbokinase - Sickle Cell Anemia
Fast track status announced for novel sickle cell anemia treatment - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
